Canada markets open in 6 hours 21 minutes

Accolade, Inc. (ACCD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.67-0.91 (-3.42%)
At close: 04:00PM EST
26.00 +0.33 (+1.29%)
After hours: 07:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close26.58
Open26.84
Bid0.00 x 900
Ask0.00 x 1400
Day's Range25.11 - 27.24
52 Week Range25.11 - 65.25
Volume996,027
Avg. Volume579,311
Market Cap1.711B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    Accolade to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

    SEATTLE, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. A presentation is available for registered attendees via the Piper Sandler conference site until December 2, 2021 or can also be accessed at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exception

  • GlobeNewswire

    Accolade to Participate in the Credit Suisse 30th Annual Healthcare Conference

    SEATTLE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Credit Suisse 30th Annual Healthcare Conference, including a fireside chat presentation on Thursday, November 11, 2021 at 12:10 p.m. E.T. A webcast and related presentation materials will be available at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exc

  • GlobeNewswire

    Accolade Announces Results for Fiscal Second Quarter 2022

    Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based careLaunched Accolade One and Accolade Care, two new healthcare solutions that combine Accolade’s intelligent technology, advocacy services and team-based healthcare delivery SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDA